- Home
- SLDP vs VNDA Comparison
SLDP vs VNDA Comparison
Compare SLDP & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDP
- VNDA
- Stock Information
- Founded
- SLDP 2011
- VNDA 2002
- Country
- SLDP United States
- VNDA United States
- Employees
- SLDP N/A
- VNDA N/A
- Industry
- SLDP Electrical Products
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- SLDP Energy
- VNDA Health Care
- Exchange
- SLDP Nasdaq
- VNDA Nasdaq
- Market Cap
- SLDP 230.9M
- VNDA 270.0M
- IPO Year
- SLDP N/A
- VNDA 2006
- Fundamental
- Price
- SLDP $1.66
- VNDA $4.36
- Analyst Decision
- SLDP Buy
- VNDA Strong Buy
- Analyst Count
- SLDP 4
- VNDA 2
- Target Price
- SLDP $2.75
- VNDA $15.50
- AVG Volume (30 Days)
- SLDP 9.9M
- VNDA 522.7K
- Earning Date
- SLDP 02-25-2025
- VNDA 02-05-2025
- Dividend Yield
- SLDP N/A
- VNDA N/A
- EPS Growth
- SLDP N/A
- VNDA N/A
- EPS
- SLDP N/A
- VNDA N/A
- Revenue
- SLDP $18,026,000.00
- VNDA $190,858,000.00
- Revenue This Year
- SLDP $2.53
- VNDA $5.60
- Revenue Next Year
- SLDP $95.43
- VNDA $42.85
- P/E Ratio
- SLDP N/A
- VNDA N/A
- Revenue Growth
- SLDP N/A
- VNDA N/A
- 52 Week Low
- SLDP $1.00
- VNDA $3.46
- 52 Week High
- SLDP $2.70
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- SLDP 51.92
- VNDA 34.28
- Support Level
- SLDP $1.49
- VNDA $4.77
- Resistance Level
- SLDP $1.81
- VNDA $4.95
- Average True Range (ATR)
- SLDP 0.27
- VNDA 0.15
- MACD
- SLDP -0.05
- VNDA -0.04
- Stochastic Oscillator
- SLDP 14.05
- VNDA 9.09
About SLDP Solid Power Inc.
Solid Power Inc is engaged in developing all-solid-state battery cell technology to enable the next generation of batteries for the EV and other markets. The company's planned business model is to license its all-solid-state battery cell designs and manufacturing know-how to top tier battery manufacturers or automotive original equipment manufacturers and to sell its sulfide-based solid electrolyte for incorporation into all-solid-state battery cells.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.